MEETINGS - GCP for medical devices in Europe: A strategic approach to medical device trials and how to comply with the European regulations (UK) October 2005:
This article was originally published in Clinica
Management Forum's GCP for medical devices in Europe: A strategic approach to medical device trials and how to comply with the European regulations will be held at the Harrington Hall Hotel, London, on October 27. Topics to include: ISO 14155, parts 1 & 2; national requirements throughout Europe; a clinical development plan; vigilance requirements during clinical investigations; and data protection during clinical investigations. To register, contact: Management Forum Ltd, 48 Woodbridge Road, Guildford GU1 4RJ, UK. Tel: +44 (0) 1483 570099; fax: +44 (0) 1483 536424; email: email@example.com; www.management-forum.co.uk
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.